dysentery: Acute inflammation of the intestine associated with infectious diarrhea of various etiologies, generally acquired by eating contaminated food containing toxins, biological derived from bacteria or other microorganisms. Dysentery is characterized initially by watery feces then by bloody mucoid stools. It is often associated with abdominal pain; fever; and dehydration.
Other specified/unspecified bacterial intestinal infections
DOID EFO Endpoint Browser PheWeb
BACT_INTEST_INFECTION_NOS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2499 |
4. Check minimum number of eventsNone |
2499 |
5. Include endpointsNone |
2499 |
6. Filter based on genotype QC (FinnGen only) |
2499 |
Control definitions (FinnGen only)
- Control exclude
- IBD_BACT_INTEST_INFECTIONS
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other specified/unspecified bacterial intestinal infections
based on the number of shared cases.
Similar with more cases:
- Bacterial intestinal infections, IBD co-morbidities
- Infections, IBD-co-morbidities
- Intestinal infectious diseases
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 19610 | 10540 | 8850 |
| Only index persons | 17779 | 9739 | 8040 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.28 | 0.30 | 0.25 |
| Only index persons | 0.33 | 0.36 | 0.31 |
| Median age at first event (years) | |||
| Whole population | 56.05 | 57.55 | 54.55 |
| Only index persons | 55.03 | 56.29 | 53.51 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2499 | 1439 | 1060 |
| Unadjusted period prevalence (%) | 0.48 | 0.49 | 0.47 |
| Median age at first event (years) | 56.93 | 54.93 | 59.66 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2278
- Matched controls
- 22779
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A04.8
ICD-10 Finland
Other specified bacterial intestinal infections
1119.8
323.0
1408
33
A04.9
ICD-10 Finland
Bacterial intestinal infection, unspecified
1203.6
323.0
791
10
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
5.1
277.3
1247
4338
A02BD07
ATC
lansoprazole, amoxicillin and clarithromycin; systemic
12.3
255.7
493
499
K29.3
ICD-10 Finland
Chronic superficial gastritis
15.0
196.3
341
265
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
138.6
134.8
143
11
A02BD03
ATC
lansoprazole, amoxicillin and metronidazole; systemic
5.7
126.3
397
807
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.6
107.5
580
1979
UJF32
NOMESCO Finland
Coloscopy
2.7
88.1
801
3818
A02BC02
ATC
pantoprazole; systemic
2.5
87.6
1631
11405
A02BDXX
ATC
NA
7.0
85.3
223
348
K29.6
ICD-10 Finland
Other gastritis
18.4
83.9
132
76
A02BD02
ATC
lansoprazole, tetracycline and metronidazole; systemic
9.1
76.2
166
194
J01MA12
ATC
levofloxacin; systemic
2.8
75.4
592
2540
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
72.1
953
5404
J01MA02
ATC
ciprofloxacin; systemic
2.2
68.8
1021
6075
P01AB01
ATC
metronidazole; oral, rectal
2.2
66.3
1017
6109
A07AA09
ATC
vancomycin; oral
24.0
61.4
88
38
00820
ICD-8 Finland
Enteritis due to other specified organism, Other specified bacteria
+∞
60.7
58
*
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
6.9
59.5
155
239
UJF30
NOMESCO Finland
Ileoscopy through colon
3.2
53.8
314
1084
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
3.1
52.5
328
1185
A02BC03
ATC
lansoprazole; oral
2.1
51.2
772
4461
A02BC05
ATC
esomeprazole; systemic
2.0
50.4
998
6425
A04.5
ICD-10 Finland
Campylobacter enteritis
67.7
46.3
53
8
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
45.8
1049
7048
A02BA07
ATC
ranitidine bismuth citrate; oral
20.2
43.2
65
33
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
43.0
376
1657
J01FA09
ATC
clarithromycin; systemic
1.9
41.5
766
4706
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.1
39.6
518
2763
XJ110
NOMESCO Finland
Respiratory helicobactery test
26.3
39.0
54
21
UJD02
NOMESCO Finland
Gastroscopy
3.7
38.6
179
513
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
38.1
546
3021
R06.0
ICD-10 Finland
Dyspnoea
2.0
36.4
607
3555
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.5
34.7
304
1328
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
34.5
421
2161
H02AB06
ATC
prednisolone; systemic
1.7
34.0
1070
7706
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
33.2
278
1185
A02BC01
ATC
omeprazole; systemic
1.8
32.8
678
4259
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
32.3
510
2903
N03AX16
ATC
pregabalin; oral
1.9
32.1
563
3333
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.8
31.7
215
809
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
31.6
277
1207
0085X
ICD-9 Finland
Intestinal infections due to other organisms, Bacterial enteritis, unspecified
+∞
31.3
30
*
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.5
31.1
275
1206
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
30.3
611
3789
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
29.6
574
3506
R51.80
ICD-10 Finland
Headache
2.2
29.0
345
1740
A07EA06
ATC
budesonide; oral, local oral
4.1
29.0
117
297
N02BE01
ATC
paracetamol; systemic, rectal
1.9
28.9
1910
16726
N02AX02
ATC
tramadol; systemic, rectal
1.7
28.6
948
6811
A07EC02
ATC
mesalazine; oral, rectal
3.1
28.1
165
563
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.7
27.8
127
360
ZX120
NOMESCO Finland
Intravenous
2.4
26.6
245
1093
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
26.1
432
2478
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
26.0
407
2285
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
25.9
739
5051
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
25.9
291
1426
D11
ICPC
Diarrhoea
2.2
24.4
259
1237
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.2
24.3
134
439
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.4
24.3
228
1026
J01DB01
ATC
cefalexin; oral
1.7
24.2
1788
15562
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
5.4
23.9
73
139
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.4
23.6
205
885
M54.5
ICD-10 Finland
Low back pain
1.6
23.2
698
4810
L04AX01
ATC
azathioprine; systemic
3.1
22.9
133
452
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
22.6
876
6439
R11
ICD-10 Finland
Nausea and vomiting
2.4
22.3
202
890
C03CA01
ATC
furosemide; systemic
1.7
22.1
635
4309
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
4.5
22.0
79
180
UJF92
NOMESCO Finland
Capsular endoscopy
4.5
21.8
78
177
J01AA07
ATC
tetracycline; systemic
1.9
21.8
342
1917
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.7
21.6
97
272
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
21.5
600
4035
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
21.0
855
6328
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
21.0
971
7406
K29.7
ICD-10 Finland
Gastritis, unspecified
3.2
21.0
111
354
K30
ICD-10 Finland
Functional dyspepsia
2.1
20.8
251
1265
R50.9
ICD-10 Finland
Fever, unspecified
1.9
20.7
312
1718
H02AB07
ATC
prednisone; oral
1.9
20.7
337
1913
S18
ICPC
Laceration/cut
1.5
20.4
895
6728
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
19.7
495
3221
R03AC02
ATC
salbutamol; inhalant
1.5
19.5
1110
8818
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
19.3
764
5585
M25.5
ICD-10 Finland
Pain in joint
1.6
19.1
592
4071
WX002
NOMESCO Finland
Sedation and analgesia
1.7
19.1
444
2819
D01
ICPC
Abdominal pain/cramps general
2.0
19.0
244
1260
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.8
18.4
122
453
K51.5
ICD-10 Finland
Left sided colitis
3.9
18.4
77
204
K92.1
ICD-10 Finland
Melaena
2.6
18.2
134
527
J01FF01
ATC
clindamycin; systemic
1.6
17.8
562
3872
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
17.8
183
859
K59.1
ICD-10 Finland
Functional diarrhoea
2.6
17.5
131
522
M79.6
ICD-10 Finland
Pain in limb
1.5
17.2
737
5453
R53
ICD-10 Finland
Malaise and fatigue
1.7
17.2
437
2838
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.1
17.0
192
940
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
16.6
1036
8284
XCK10
NOMESCO Finland
Photography of fundus of eye
2.0
16.2
231
1241
A02BA02
ATC
ranitidine; systemic
1.6
16.2
432
2838
AA1AD
NOMESCO Finland
CT of head and brain
1.6
16.1
505
3459
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
16.1
376
2377
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.0
16.0
94
324
R42
ICD-10 Finland
Dizziness and giddiness
1.6
16.0
467
3143
ZXD05
NOMESCO Finland
Urgent procedure
1.5
15.9
647
4716
L03
ICPC
Low back symptom/complaint
1.6
15.8
495
3387
Z3226
NOMESCO Finland
Physiotherapist
1.6
15.5
402
2618
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
15.5
1431
12282
Z2221
NOMESCO Finland
Medical doctor
1.5
15.4
580
4148
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.4
15.4
128
542
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
15.4
267
1538
J02AC01
ATC
fluconazole; systemic
1.5
15.3
788
6030
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.9
14.9
92
327
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.1
14.9
174
862
N05CF01
ATC
zopiclone; oral
1.5
14.8
662
4908
C07AB07
ATC
bisoprolol; oral
1.4
14.7
969
7766
Z3231
NOMESCO Finland
Registered nurse
1.5
14.7
572
4116
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
14.7
327
2039
K26.9
ICD-10 Finland
Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation
7.3
14.5
34
47
K50.9
ICD-10 Finland
Crohn disease, unspecified
4.7
14.5
49
107
K29.4
ICD-10 Finland
Chronic atrophic gastritis
3.4
14.4
70
212
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
14.2
1104
9105
H02AB04
ATC
methylprednisolone; systemic
1.7
14.2
311
1926
N06AX11
ATC
mirtazapine; oral
1.5
14.1
639
4739
WX110
NOMESCO Finland
Local anesthesy
1.4
14.1
1402
12086
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
14.0
371
2425
G44.2
ICD-10 Finland
Tension-type headache
1.8
14.0
269
1603
K26.3
ICD-10 Finland
Duodenal ulcer, acute without haemorrhage or perforation
8.4
14.0
30
36
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
14.0
354
2283
N03AX12
ATC
gabapentin; oral
1.7
14.0
319
2002
K25.3
ICD-10 Finland
Gastric ulcer, Acute without haemorrhage or perforation
6.4
14.0
36
57
Z01.2
ICD-10 Finland
Dental examination
1.4
13.9
819
6404
R03BB04
ATC
tiotropium bromide; inhalant
1.9
13.6
207
1136
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.2
13.6
70
221
K50.1
ICD-10 Finland
Crohn disease of large intestine
5.2
13.5
41
80
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
13.5
320
2029
SPAT1255
SPAT
Intravenous administration of medicine
2.1
13.4
146
705
N02AA05
ATC
oxycodone; systemic
1.7
13.3
305
1913
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
13.3
266
1602
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.0
13.3
185
984
JN4BD
NOMESCO Finland
Extensive body CT
1.8
13.2
229
1318
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
13.1
356
2340
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.3
13.1
128
586
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
13.1
240
1407
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
13.0
270
1642
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
13.0
349
2286
N06AX21
ATC
duloxetine; oral
1.8
12.9
223
1281
A04
ICPC
Weakness/tiredness general
1.7
12.9
275
1688
R13
ICD-10 Finland
Dysphagia
2.1
12.8
144
705
UKC02
NOMESCO Finland
Cystoscopy
1.6
12.8
329
2132
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.0
12.7
154
778
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
12.7
184
995
A02BC04
ATC
rabeprazole; oral
2.0
12.7
176
936
K50.0
ICD-10 Finland
Crohn disease of small intestine
4.3
12.4
45
106
J01DA01
ATC
[U] cefalexin; systemic
1.4
12.4
1282
11000
M03BX02
ATC
tizanidine; oral
1.4
12.4
1220
10377
D06
ICPC
Abdominal pain localized other
1.9
12.3
177
955
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
12.1
461
3277
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.8
12.1
79
291
SPAT1254
SPAT
Administration of medicine
1.6
12.1
305
1966
J01AA02
ATC
doxycycline; systemic
1.4
12.0
1626
14570
R12
ICD-10 Finland
Heartburn
2.0
11.9
148
754
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
11.8
444
3145
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.1
11.8
141
707
ZXA00
NOMESCO Finland
Right side
1.5
11.8
552
4101
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.7
11.7
78
293
A99
ICPC
Disease/condition unspecnature/site
1.9
11.7
167
898
A41.9
ICD-10 Finland
Sepsis, unspecified
2.6
11.7
82
318
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
11.7
433
3059
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
11.7
296
1906
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
11.6
282
1798
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
11.5
323
2136
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
11.5
939
7706
K50.8
ICD-10 Finland
Other Crohn disease
3.9
11.5
46
120
SPAT1104
SPAT
Monitoring of emergency patient
2.0
11.4
147
761
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
7.5
11.4
26
35
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.9
11.4
166
898
SPAT1262
SPAT
Handing over of treatment supplies
1.6
11.2
359
2452
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
11.2
222
1334
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.8
11.2
71
260
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
11.2
235
1437
M01AE02
ATC
naproxen; oral, rectal
1.4
11.2
1121
9500
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.8
11.2
192
1102
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
5.2
11.0
33
64
K51.8
ICD-10 Finland
Other ulcerative colitis
4.5
11.0
38
86
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
11.0
117
560
R07.3
ICD-10 Finland
Other chest pain
1.8
11.0
198
1155
K02.1
ICD-10 Finland
Caries of dentine
1.4
11.0
1104
9349
J01FA06
ATC
roxithromycin; oral
1.4
11.0
809
6510
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
10.8
776
6213
L28
ICPC
Limited function/disability (L)
1.6
10.7
312
2080
N03AE01
ATC
clonazepam; systemic
2.1
10.7
126
627
SPAT1263
SPAT
Sampling
1.4
10.7
852
6939
D02
ICPC
Abdominal pain epigastric
2.1
10.7
119
580
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
10.6
1262
10945
Z2446
NOMESCO Finland
Social worker
2.0
10.6
140
732
A02BX
ATC
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
3.7
10.6
45
124
XF402
NOMESCO Finland
ECG with work load test
1.7
10.5
230
1422
R02
ICPC
Shortness of breath/dyspnoea
1.7
10.5
246
1554
H25.8
ICD-10 Finland
Other senile cataract
1.7
10.4
221
1353
D09
ICPC
Nausea
2.4
10.4
89
385
C01CA24
ATC
epinephrine; parenteral
2.1
10.3
119
589
H02AB09
ATC
hydrocortisone; systemic
3.1
10.3
54
175
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
10.3
533
4021
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
10.3
399
2844
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
10.3
730
5825
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
4.5
10.2
35
79
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
10.2
1032
8708
M01AH05
ATC
etoricoxib; oral
1.3
10.2
1148
9847
R01AD08
ATC
fluticasone; nasal
1.4
10.2
539
4083
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.9
10.2
143
767
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.1
10.1
113
553
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.7
10.1
69
265
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.5
10.1
448
3282
N01
ICPC
Headache
1.7
10.1
195
1163
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
10.1
319
2172
L01
ICPC
Neck symptom/complaint
1.6
10.0
260
1686
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
9.9
151
833
G47.3
ICD-10 Finland
Sleep apnoea
1.5
9.9
393
2808
A03CA02
ATC
clidinium and psycholeptics; oral
2.0
9.9
133
701
N05CD07
ATC
temazepam; oral
1.6
9.9
257
1668
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
9.8
191
1139
N05BA04
ATC
oxazepam; oral
1.4
9.8
478
3561
K29.8
ICD-10 Finland
Duodenitis
4.8
9.8
31
65
R52.9
ICD-10 Finland
Pain, unspecified
1.8
9.7
165
943
ZXE00
NOMESCO Finland
One hour or less
1.3
9.6
781
6353
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.1
9.6
105
511
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
9.5
227
1437
A06AD11
ATC
lactulose; oral
1.5
9.5
300
2041
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
9.5
1158
10007
J01MA14
ATC
moxifloxacin; systemic
1.8
9.5
172
1005
M01AH01
ATC
celecoxib; oral (coxibs)
1.5
9.4
356
2519
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
2.3
9.4
88
398
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
9.3
370
2643
R52.2
ICD-10 Finland
Other chronic pain
2.5
9.3
71
292
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
9.3
97
461
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.7
9.2
182
1089
TKC20
NOMESCO Finland
Catheterisation of bladder
1.9
9.2
135
734
J05AB01
ATC
aciclovir; systemic
1.5
9.2
399
2905
M54
ICD-10 Finland
Dorsalgia
1.6
9.2
216
1364
-1
NOMESCO Finland
NA
1.4
9.1
627
4954
A02.0
ICD-10 Finland
Salmonella enteritis
8.3
9.1
19
23
E86
ICD-10 Finland
Volume depletion
2.9
9.0
53
186
WW500
NOMESCO Finland
Blood transfusion
2.3
9.0
83
372
J01MA06
ATC
norfloxacin; oral
1.6
9.0
266
1779
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
9.0
573
4469
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.0
9.0
109
551
P03
ICPC
Feeling depressed
1.8
9.0
159
923
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.8
9.0
159
923
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
8.9
194
1197
A46
ICD-10 Finland
Erysipelas
1.6
8.9
263
1759
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
8.8
132
723
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
8.8
565
4411
D50.8
ICD-10 Finland
Other iron deficiency anaemias
3.8
8.8
36
97
XG410
NOMESCO Finland
Flow-volume spirometry
2.2
8.8
84
384
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
8.8
632
5028
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.3
8.7
81
365
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.3
8.7
79
354
RD210
NOMESCO Finland
NA
3.0
8.7
47
157
R20.2
ICD-10 Finland
Paraesthesia of skin
1.9
8.7
119
631
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
8.7
401
2951
R63.4
ICD-10 Finland
Abnormal weight loss
2.4
8.7
72
307
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.3
8.7
75
327
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
8.7
289
1988
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
4.5
8.7
29
65
NF1AA
NOMESCO Finland
Hip X-ray examination
1.7
8.6
173
1041
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
8.6
353
2536
N06AB10
ATC
escitalopram; oral
1.5
8.6
349
2503
A07AA02
ATC
nystatin; oral
1.9
8.6
132
732
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
8.6
1089
9409
L08
ICPC
Shoulder symptom/complaint
1.5
8.6
363
2627
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.3
8.5
72
312
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
8.5
207
1320
SPAT1240
SPAT
Therapeutic discussion
1.7
8.5
185
1146
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
8.4
436
3275
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
8.4
390
2873
M79.1
ICD-10 Finland
Myalgia
1.6
8.4
234
1543
XW000
NOMESCO Finland
Bone marrow biopsy
2.2
8.4
81
372
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.4
8.4
70
300
M01AH02
ATC
rofecoxib; oral
1.5
8.4
257
1736
N03AG01
ATC
valproic acid; systemic, rectal
1.9
8.3
111
586
J04AB04
ATC
rifabutin; oral
+∞
8.3
8
*
WX892
NOMESCO Finland
Monitored bed care
1.8
8.3
150
877
Z00.0
ICD-10 Finland
General medical examination
1.5
8.3
348
2510
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.1
8.3
93
457
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.9
8.3
124
680
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
8.3
182
1128
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.8
8.3
51
186
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
10.8
8.3
15
14
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.8
8.2
149
874
R4110
NOMESCO Finland
Physiotherapy
1.4
8.2
505
3913
R51
ICD-10 Finland
Headache
2.0
8.2
99
505
A04AA01
ATC
ondansetron; systemic, rectal
1.8
8.1
132
745
K03.64
ICD-10 Finland
Dental calculus supragingival
1.4
8.1
497
3843
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
8.1
231
1531
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.8
8.1
144
838
J20
ICD-10 Finland
Acute bronchitis
1.7
8.1
173
1065
N30.9
ICD-10 Finland
Cystitis, unspecified
1.9
8.1
116
627
R05
ICPC
Cough
1.4
8.1
411
3078
M02AA07
ATC
piroxicam; topical
1.3
8.0
710
5813
J37.0
ICD-10 Finland
Chronic laryngitis
2.4
8.0
66
283
K59.09
ICD-10 Finland
Constipation, unspecified
1.9
8.0
120
662
A28
ICPC
Limited function/disability NOS
1.5
8.0
278
1930
DFF00
NOMESCO Finland
Pure tone audiometry
1.7
8.0
170
1044
ZXA05
NOMESCO Finland
Left side
1.4
7.9
491
3807
C10AC01
ATC
colestyramine; oral
2.7
7.9
52
198
ZXE20
NOMESCO Finland
More than three and less than five hours
1.5
7.9
266
1834
J01CA04
ATC
amoxicillin; systemic
1.3
7.9
1658
15257
JAH00
NOMESCO Finland
Laparotomy
2.5
7.9
58
234
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
7.9
299
2113
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.6
7.8
54
209
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
2.6
7.8
52
199
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
7.8
815
6822
SPAT1167
SPAT
Insertion of urinary catheter
2.4
7.8
64
275
T78.4
ICD-10 Finland
Allergy, unspecified
2.1
7.7
82
396
C08CA01
ATC
amlodipine; oral
1.3
7.7
673
5496
R31
ICD-10 Finland
Unspecified haematuria
1.6
7.7
182
1149
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.7
7.7
49
181
JN4CD
NOMESCO Finland
Very extensive body CT
2.2
7.7
75
350
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
7.7
556
4416
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
7.7
448
3434
J01FA10
ATC
azithromycin; systemic
1.3
7.7
1107
9673
A07EA02
ATC
hydrocortisone; rectal
2.6
7.7
51
196
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
7.6
527
4150
A29
ICPC
General symptom/complaint other
1.6
7.6
203
1325
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.7
7.6
150
899
XKD00
NOMESCO Finland
Uroflowmetry
1.5
7.6
275
1925
B01AB05
ATC
enoxaparin; parenteral
1.3
7.6
590
4736
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
7.6
120
675
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.1
7.6
38
122
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.9
7.6
102
540
N06AA09
ATC
amitriptyline; systemic
1.6
7.6
196
1268
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
7.5
250
1717
N05AH04
ATC
quetiapine; oral
1.5
7.4
287
2036
M01AB05
ATC
diclofenac; systemic, rectal
1.3
7.4
1306
11678
XF404
NOMESCO Finland
Ambulatory ECG
1.6
7.4
181
1155
R06AE07
ATC
cetirizine; oral
1.3
7.4
813
6845
B82
ICPC
Anaemia other/unspecified
2.7
7.4
48
181
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.7
7.4
155
950
A07AA11
ATC
rifaximin; oral
13.4
7.4
12
9
N30.0
ICD-10 Finland
Acute cystitis
1.5
7.4
260
1811
R03BA05
ATC
fluticasone; inhalant
1.4
7.4
346
2549
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.8
7.3
125
717
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.0
7.3
86
433
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
7.3
251
1738
C01AA05
ATC
digoxin; systemic
1.7
7.3
151
921
00830
ICD-8 Finland
Enteritis due to other specified organism, Bacterial enteritis, unspecified
+∞
7.3
7
*
N06AX16
ATC
venlafaxine; oral
1.5
7.3
242
1663
K52.80
ICD-10 Finland
(Hemorrhagic) colitis caused by antibiotics
10.9
7.3
13
12
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
2.4
7.3
58
246
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.6
7.3
199
1307
R74
ICPC
Upper respiratory infection acute
1.4
7.2
483
3780
ZX100
NOMESCO Finland
Oral
3.4
7.2
33
99
N17
ICPC
Vertigo/dizziness
1.5
7.2
215
1440
K29.1
ICD-10 Finland
Other acute gastritis
3.1
7.2
37
121
R00.2
ICD-10 Finland
Palpitations
1.8
7.2
129
752
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
7.2
733
6102
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.5
7.2
31
89
A01AB09
ATC
miconazole; local oral
1.6
7.2
175
1115
WZA90
NOMESCO Finland
Other doctors statement
1.4
7.2
416
3184
L12
ICPC
Hand/finger symptom/complaint
1.5
7.2
256
1787
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.9
7.2
99
530
KMAK
NOMESCO Finland
NA
1.3
7.1
970
8382
SPAT1216
SPAT
Assessment of functional ability
1.5
7.1
290
2077
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
1.8
7.1
118
673
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.4
7.1
425
3266
R03AC03
ATC
terbutaline; inhalant
1.5
7.1
258
1810
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.7
7.1
142
859
K92.0
ICD-10 Finland
Haematemesis
2.7
7.1
46
174
M04AA01
ATC
allopurinol; systemic
1.5
7.1
229
1563
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.7
7.0
140
845
A11CC03
ATC
alfacalcidol; systemic
2.6
7.0
47
182
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.8
7.0
122
707
R21
ICPC
Throat symptom/complaint
1.4
7.0
333
2458
J01
ICD-10 Finland
Acute sinusitis
2.0
7.0
87
447
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.7
7.0
149
917
J46
ICD-10 Finland
Status asthmaticus
2.3
6.9
58
251
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
6.9
257
1807
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.6
6.9
171
1096
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
2.2
6.9
67
313
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
2.4
6.9
53
222
R05
ICD-10 Finland
Cough
1.4
6.9
361
2713
A11
ICPC
Chest pain NOS
1.7
6.9
143
874
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.3
6.9
32
98
R03DC03
ATC
montelukast; oral
1.4
6.9
285
2052
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
6.9
202
1349
J31.0
ICD-10 Finland
Chronic rhinitis
1.7
6.8
138
836
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.6
6.8
45
172
J01FA01
ATC
erythromycin; systemic
1.5
6.8
241
1679
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.8
6.8
104
576
WZC30
NOMESCO Finland
Teaching
1.5
6.8
235
1629
J45
ICD-10 Finland
Asthma
1.6
6.8
170
1092
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.7
6.8
146
901
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.7
6.8
44
166
H57.1
ICD-10 Finland
Ocular pain
2.3
6.8
60
267
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.9
6.8
100
550
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.1
6.8
68
322
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.4
6.8
437
3399
J01DC02
ATC
cefuroxime; systemic
1.8
6.8
104
581
JFA56
NOMESCO Finland
Faecal microbiota transplantation
40.2
6.8
8
*
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.5
6.8
266
1893
R03BB01
ATC
ipratropium bromide; inhalant
2.0
6.7
79
397
A03
ICPC
Fever
1.5
6.7
263
1868
N05CF02
ATC
zolpidem; oral
1.4
6.7
311
2284
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.6
6.7
47
185
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.7
6.7
133
801
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
6.7
495
3930
A01
ICPC
Pain general/multiple sites
1.7
6.7
143
882
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.8
6.7
119
695
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.1
6.7
67
317
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.5
6.7
48
194
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
2.6
6.6
45
176
E66.8
ICD-10 Finland
Other obesity
1.9
6.6
93
502
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
6.6
435
3389
N07BA03
ATC
varenicline; oral
1.9
6.6
87
461
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.2
6.6
61
277
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
6.6
492
3917
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
2.8
6.5
39
141
J01DA06
ATC
[U] cefuroxime; systemic
1.4
6.5
274
1976
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
6.5
695
5809
L50.8
ICD-10 Finland
Other urticaria
2.8
6.5
39
142
J01EA01
ATC
trimethoprim; systemic
1.3
6.4
478
3795
Z71.8
ICD-10 Finland
Other specified counselling
1.3
6.4
415
3227
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
6.4
187
1246
R10.0
ICD-10 Finland
Acute abdomen
2.2
6.4
58
262
A07AA12
ATC
fidaxomicin; oral
70.0
6.4
7
*
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
2.0
6.4
77
393
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.5
6.4
203
1380
L17
ICPC
Foot/toe symptom/complaint
1.3
6.4
458
3616
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.8
6.4
106
606
SPAT1229
SPAT
Assessment of need for aid
1.6
6.4
145
912
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
2.6
6.3
43
169
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
6.3
392
3026
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
11.0
6.3
11
10
L13
ICPC
Hip symptom/complaint
1.4
6.3
283
2070
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.6
6.3
172
1131
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
2.7
6.3
41
156
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
6.3
779
6625
N05BA01
ATC
diazepam; systemic, rectal
1.5
6.2
243
1725
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
1.8
6.2
95
527
A03FA02
ATC
cisapride; oral, rectal
1.6
6.2
150
958
K25.4
ICD-10 Finland
Gastric ulcer, Chronic or unspecified with haemorrhage
4.1
6.2
22
54
S06.0
ICD-10 Finland
Concussion
1.5
6.2
183
1227
N76.0
ICD-10 Finland
Acute vaginitis
1.9
6.2
83
440
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
3.8
6.2
24
64
R96
ICPC
Asthma
1.6
6.2
157
1015
M54.2
ICD-10 Finland
Cervicalgia
1.7
6.2
123
744
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
4.5
6.2
20
45
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.0
6.2
75
386
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.8
6.2
93
517
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
6.1
152
974
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.8
6.1
95
533
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.9
6.1
81
430
A02BB01
ATC
misoprostol; oral
4.7
6.1
19
41
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.6
6.1
137
856
JFF13
NOMESCO Finland
Terminal enterostomy
12.5
6.1
10
8
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
6.1
189
1282
N06AB04
ATC
citalopram; systemic
1.3
6.1
392
3048
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
6.1
132
817
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.6
6.1
40
154
A12AA04
ATC
calcium carbonate; oral
2.9
6.1
33
114
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.8
6.0
36
131
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.9
6.0
84
453
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
6.7
6.0
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013139) Helicobacter pylori Ag [Presence] in Stool
560
1300
5.26
232.55
1.7
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
155
85
19.38
196.00
1.2
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
736
2825
3.28
145.24
1.3
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
451
1375
3.78
126.23
2.4
1.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1566
10604
2.28
83.06
7.9
6.1
umol/l
11.2
11.5
0.33
1494
10030
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1078
6331
2.24
80.60
3.4
2.5
u/l
57.4
57.8
0.07
1018
5830
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
209
534
4.18
73.57
1.5
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1097
6880
2.06
65.31
8.2
5.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1400
9608
2.04
64.64
8.4
5.9
%
57.6
57.3
0.34
1299
8978
(3006504) Eosinophils/100 leukocytes in Blood
1385
9469
2.04
64.62
8.7
6.0
%
2.7
2.8
1.09
1283
8812
(3019069) Monocytes/100 leukocytes in Blood
1388
9509
2.03
64.25
9.1
6.2
%
8.6
8.7
0.43
1288
8889
(3002030) Lymphocytes/100 leukocytes in Blood
1413
9755
2.03
63.85
8.8
6.1
%
27.2
27.8
1.21
1308
9081
(3022096) Basophils/100 leukocytes in Blood
1350
9198
2.02
62.99
8.6
6.0
%
0.7
0.7
0.16
1251
8574
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
891
5251
2.08
62.09
3.0
2.2
mg/l
3.0
3.0
0.00
781
4447
(3006315) Basophils [#/volume] in Blood
1434
10097
1.99
59.56
8.3
5.8
e9/l
0.0
0.0
0.22
1259
8701
(3023368) Bacteria identified in Blood by Culture
919
5546
2.04
59.45
5.6
4.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1986
15799
2.25
58.19
11.6
7.3
u/l
80.2
78.6
0.66
1903
14851
(3019198) Lymphocytes [#/volume] in Blood
1455
10346
1.97
58.14
8.3
5.8
e9/l
1.9
1.9
0.04
1303
9093
(3013115) Eosinophils [#/volume] in Blood
1465
10449
1.97
57.93
8.7
6.0
e9/l
0.2
0.2
0.13
1309
9144
(3001604) Monocytes [#/volume] in Blood
1423
10057
1.96
57.72
8.3
5.8
e9/l
0.6
0.6
1.04
1251
8664
(3024561) Albumin [Mass/volume] in Serum or Plasma
1296
8876
1.96
57.68
7.1
4.6
g/l
35.1
35.4
1.05
1213
8251
(3048689) Calprotectin [Mass/mass] in Stool
485
2298
2.38
57.60
3.5
2.2
ug/g
222.0
129.1
2.62
401
1818
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1262
8625
1.94
55.89
3.9
2.8
ug/l
117.9
127.3
0.65
1182
7939
(3013650) Neutrophils [#/volume] in Blood by Automated count
1573
11788
1.90
50.28
12.7
8.9
e9/l
4.1
4.1
0.06
1381
10254
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1207
8412
1.84
47.59
2.4
2.0
pmol/l
97.1
94.5
0.95
687
4327
(3022948) Iron [Moles/volume] in Serum or Plasma
578
3157
2.08
47.36
3.1
2.4
umol/l
12.0
13.0
2.76
535
2924
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
517
2707
2.15
47.34
3.2
2.5
%
20.0
22.9
4.48
435
2332
(3004789) Transferrin [Mass/volume] in Serum or Plasma
540
2918
2.09
45.31
3.1
2.4
g/l
2.3
2.3
0.00
496
2710
(3013826) Glucose [Moles/volume] in Serum or Plasma
1562
11989
1.81
42.78
6.3
4.7
mmol/l
6.7
6.7
0.14
1486
11225
(3025941) Bacteria identified in Stool by Culture
259
1050
2.64
42.25
1.5
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
139
402
3.60
40.75
1.6
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
964
6495
1.79
40.61
3.1
2.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1654
13024
1.80
40.35
4.5
3.1
u/l
57.5
48.7
1.70
1552
12074
(3019309) Folate [Moles/volume] in Red Blood Cells
642
3835
1.91
39.78
1.8
1.7
nmol/l
1068.9
1187.7
2.50
514
2884
(3032080) INR in Blood by Coagulation assay
1156
8256
1.74
39.39
9.8
9.4
inr
1.2
1.3
1.01
255
2365
(3007164) IgA [Mass/volume] in Serum or Plasma
643
3856
1.90
39.30
1.7
1.4
g/l
2.4
2.4
0.34
363
2298
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
432
2254
2.11
39.26
3.3
2.6
umol/l
8.6
8.3
0.08
368
1978
(3037467) Urinalysis macro (dipstick) panel - Urine
1742
14032
1.80
38.17
6.0
4.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1370
10316
1.73
38.11
9.7
6.5
mmol/l
1.2
1.2
0.24
1203
8693
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
430
2267
2.08
37.91
4.1
4.4
u/l
239.7
251.7
0.62
395
2150
(3022145) Colonoscopy Study observation
423
2224
2.09
37.54
1.5
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1835
15045
1.83
37.50
5.7
4.0
mm/h
14.1
12.4
4.47
1721
13881
(3031040) Bacteria [#/volume] in Urine by Automated count
1682
13469
1.76
36.95
6.0
4.5
e6/l
2572.5
1627.0
0.14
23
206
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1263
9363
1.71
36.64
8.4
5.8
mmol/l
1.2
1.2
1.74
1174
8450
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
188
721
2.74
34.06
2.1
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
758
4971
1.75
33.64
3.0
2.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
163
583
2.92
33.64
1.9
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
426
2337
1.99
33.31
2.9
2.6
%
1.8
1.8
0.03
376
2086
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
281
1315
2.28
33.23
4.2
3.5
kpa
5.2
5.2
0.04
263
1218
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
271
1250
2.31
33.16
4.2
3.5
mmol/l
1.5
1.8
0.66
207
924
(3009343) pH of Capillary blood
278
1301
2.28
32.86
4.3
3.5
ph
7.4
7.4
0.02
22
155
(3038177) Helicobacter pylori Ab [Presence] in Serum
105
292
3.71
32.61
1.8
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
929
6519
1.68
31.76
4.5
3.1
u/l
30.2
33.5
2.51
879
6198
(3019225) pH of Specimen
382
2073
1.99
30.62
5.1
4.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
884
6171
1.67
30.54
2.4
2.1
u/l
170.8
223.2
1.54
825
5781
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
121
386
3.24
30.40
5.8
4.8
iu/ml
251.3
527.7
1.14
15
49
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1134
8461
1.62
29.87
3.0
2.2
nmol/l
76.6
77.8
0.76
1030
7557
(3013512) EKG study
861
5998
1.66
29.82
4.7
3.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
198
832
2.50
29.75
2.1
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
541
3324
1.80
29.46
2.1
1.8
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
533
3282
1.79
28.73
4.1
3.4
mmol/l
0.8
0.8
1.19
499
3062
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
194
825
2.47
28.39
4.4
3.7
mmol/l
24.6
24.9
0.52
178
771
(3022313) Gas panel - Capillary blood
215
958
2.36
28.37
4.1
3.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
293
1482
2.11
28.36
3.2
2.9
g/l
10.2
10.6
0.96
263
1354
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
348
1889
1.98
27.71
2.9
2.3
u/l
32.5
64.6
0.69
290
1626
(3021960) Folate [Moles/volume] in Serum or Plasma
717
4853
1.67
27.26
1.8
1.5
nmol/l
20.1
20.7
0.49
637
4136
(3028026) IgM [Mass/volume] in Serum or Plasma
243
1163
2.21
27.04
1.9
1.8
g/l
1.2
1.4
1.27
212
1059
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
180
759
2.48
26.81
1.9
1.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
430
2542
1.84
26.29
4.8
4.5
%
32.6
32.6
0.01
336
1689
(42529406) Shigella sp [Presence] in Stool by Culture
149
587
2.64
25.55
1.4
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
652
4374
1.66
25.35
1.4
1.3
u/ml
2.3
1.5
0.40
129
1148
(3026493) Urate [Moles/volume] in Serum or Plasma
760
5306
1.62
25.18
3.2
2.7
umol/l
2360.1
5662.5
2.20
663
4572
(3014765) Yersinia sp identified in Stool by Organism specific culture
147
582
2.62
24.95
1.4
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
610
4039
1.68
24.87
3.7
2.7
mosm/kgh2o
546.5
546.7
0.01
529
3437
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1032
7770
1.56
24.62
4.7
3.6
ng/l
46.0
52.5
0.20
755
5367
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
145
575
2.62
24.53
1.4
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
653
4414
1.65
24.52
1.9
1.8
mg/l
1.0
1.2
0.68
501
3366
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2237
20281
1.98
24.26
24.9
14.2
mg/l
23.2
24.1
0.68
1926
16077
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1217
9533
1.54
24.09
5.1
4.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
312
1720
1.93
23.55
3.0
2.6
e9/l
66.4
70.0
1.12
238
1302
(3033658) Prothrombin time (PT) actual/Normal
735
5174
1.60
23.16
5.6
3.8
%
90.0
89.3
0.28
717
5050
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
42
75
5.68
22.58
1.3
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
42
75
5.68
22.58
1.3
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
337
1934
1.86
22.43
2.9
2.2
g/l
0.2
0.2
0.15
318
1809
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
193
907
2.22
22.39
1.8
1.9
g/l
1.6
1.5
0.15
161
794
(40768804) Tissue Pathology biopsy report
1067
8240
1.51
21.83
2.3
2.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
856
6310
1.54
21.74
4.0
3.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
140
583
2.48
21.40
1.5
1.4
ug/g
287.8
283.7
0.09
93
338
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
590
4004
1.62
21.37
4.1
3.7
ng/l
420.2
427.4
0.02
440
3134
(3037522) Nuclear Ab [Titer] in Serum
422
2625
1.73
21.34
1.5
1.3
titre
461.5
503.3
0.22
91
554
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
78
238
3.35
21.09
1.7
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
78
238
3.35
21.09
1.7
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
78
239
3.34
20.96
1.7
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
498
3263
1.66
20.67
3.7
2.9
e6/l
3.5
2.5
1.17
302
1760
(40758558) Short blood count panel - Blood
721
5177
1.55
20.35
9.5
6.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
77
239
3.29
20.27
1.7
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
948
7222
1.50
20.26
5.2
3.7
e6/l
110.6
109.8
0.01
697
5105
(3002582) Erythrocytes [#/volume] in Urine
832
6178
1.52
20.05
4.4
3.3
e6/l
30.1
89.7
3.23
664
4739
(3017143) Hepatitis C virus Ab [Presence] in Serum
350
2100
1.78
20.00
1.8
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
77
242
3.25
19.87
1.7
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
46
100
4.67
19.86
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
383
2365
1.73
19.77
1.6
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
77
243
3.24
19.74
1.7
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
320
1878
1.81
19.68
2.4
2.1
nmol/l
359.7
373.5
0.57
293
1713
(3022217) INR in Platelet poor plasma by Coagulation assay
422
2680
1.69
19.65
24.0
25.0
inr
1.4
1.4
0.03
67
369
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
46
101
4.62
19.63
1.3
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
445
2879
1.66
19.28
2.5
2.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
802
6006
1.49
18.15
3.2
3.1
ng/l
1451.7
1445.8
0.02
693
5127
(3003458) Phosphate [Moles/volume] in Serum or Plasma
418
2700
1.66
18.13
8.5
5.3
mmol/l
1.1
1.0
0.39
393
2494
(3021879) Hepatitis B virus core Ab [Presence] in Serum
244
1354
1.89
17.89
1.5
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
127
550
2.38
17.84
1.4
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
192
987
2.02
17.60
1.4
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2259
20927
1.83
17.48
26.4
16.4
mmol/l
139.5
139.7
1.31
2229
20388
(46235355) HIV 1 and 2 tests - Meaningful Use set
467
3144
1.60
17.04
1.9
1.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2052
18566
1.59
17.03
5.5
4.8
mu/l
1.9
2.0
1.50
1914
16930
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
498
3419
1.57
16.68
1.4
1.3
iu/ml
27.4
35.8
1.02
143
1078
(3023103) Potassium [Moles/volume] in Serum or Plasma
2260
20987
1.80
16.67
26.7
16.5
mmol/l
4.0
4.0
0.03
2224
20415
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
479
3265
1.58
16.53
1.3
1.2
u/ml
8.6
12.4
0.58
135
1251
(3030467) Casts [#/volume] in Urine by Automated count
751
5648
1.47
16.27
4.3
3.1
e6/l
0.4
0.5
0.56
578
4261
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
399
2624
1.62
15.96
1.7
1.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
300
1832
1.72
15.94
9.8
6.8
mmol/l
10.8
9.6
1.99
286
1743
(3002032) Base excess in Venous blood by calculation
310
1913
1.71
15.86
7.2
3.5
mmol/l
1.9
2.1
0.36
252
1539
(3000850) Epithelial cells [#/volume] in Urine
598
4325
1.50
15.64
3.4
2.6
e6/l
6.1
5.8
0.24
533
3791
(3018677) aPTT in Platelet poor plasma by Coagulation assay
455
3102
1.57
15.61
2.4
2.1
s
30.0
29.8
0.30
442
3003
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
220
1237
1.85
15.44
1.9
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
497
3480
1.53
15.08
3.4
2.7
e6/l
1.2
1.1
0.14
294
1964
(3006462) Nitrate [Presence] in Urine
39
93
4.24
15.06
3.9
3.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1757
15537
1.44
14.93
4.4
4.0
pmol/l
14.7
14.8
0.87
1616
14075
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
213
1199
1.85
14.89
1.5
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
364
2379
1.62
14.87
1.9
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2079
19025
1.55
14.72
20.6
13.4
ml/min/173m2
80.1
80.0
0.03
1787
15672
(36304419) Bacteria [Presence] in Urine
726
5512
1.45
14.68
4.2
3.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1437
12304
1.40
14.42
3.3
2.9
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
142
704
2.08
14.37
2.5
2.3
ug/l
502.3
487.9
0.03
131
662
(36660697) Celiac disease serology panel - Serum
257
1549
1.73
14.27
1.2
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
156
803
2.01
14.25
2.9
2.4
g/l
7.6
7.4
0.69
105
612
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
33
72
4.63
14.23
1.5
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
155
802
1.99
13.95
2.9
2.4
g/l
3.7
3.8
0.49
100
588
(3021447) Carbon dioxide [Partial pressure] in Venous blood
304
1929
1.66
13.93
7.4
3.5
kpa
5.8
5.8
0.45
292
1879
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
155
803
1.99
13.90
2.9
2.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
153
789
2.00
13.90
1.9
1.9
ug/l
2.1
2.3
0.07
136
693
(3004588) Protein electrophoresis panel - Serum or Plasma
236
1405
1.75
13.68
3.1
2.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
256
1566
1.71
13.46
5.0
3.6
ng/l
92.8
87.7
0.39
223
1356
(3037121) Protein [Mass/volume] in Urine
140
713
2.02
13.18
3.7
3.2
g/l
0.4
0.3
0.73
62
283
(4211845)
39
104
3.79
12.99
4.0
3.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
145
753
1.98
12.93
3.0
2.5
g/l
3.1
3.1
0.08
101
598
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
122
598
2.09
12.74
1.7
1.6
iu/ml
0.2
0.1
0.01
28
110
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
23
40
5.79
12.73
1.6
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
60
217
2.81
12.25
3.2
3.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
267
1695
1.64
12.16
3.5
2.7
g/l
65.5
66.5
1.28
238
1543
(3015377) Calcium [Moles/volume] in Serum or Plasma
875
7042
1.37
12.13
3.8
3.3
mmol/l
2.3
2.4
2.11
736
6148
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
187
1078
1.79
12.09
2.7
2.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
141
745
1.95
11.97
2.5
2.5
g/l
10.4
10.3
0.11
111
641
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
66
256
2.62
11.79
7.9
6.8
mg/l
11.2
11.8
0.54
60
235
(3004809) Band form neutrophils/100 leukocytes in Blood
78
331
2.40
11.55
3.1
3.5
%
2.3
1.4
0.82
65
259
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
172
982
1.81
11.49
8.2
3.9
mmol/l
24.3
24.1
0.40
157
900
(3014111) Lactate [Moles/volume] in Serum or Plasma
277
1802
1.60
11.42
7.9
7.1
mmol/l
1.3
1.4
0.23
261
1737
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2274
21510
1.64
11.10
16.1
10.3
u/l
25.7
26.0
0.32
2213
20738
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
81
356
2.32
11.10
1.2
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
766
6110
1.37
10.99
6.5
3.9
ph
7.4
7.4
0.28
123
1170
(3000991) Gas panel - Venous blood
265
1728
1.60
10.80
11.6
8.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
91
425
2.18
10.80
3.2
2.9
umol/l
30.8
35.8
1.40
79
354
(3030981) Hyaline casts [#/volume] in Urine by Automated count
178
1048
1.75
10.72
3.3
2.8
e6/l
0.2
0.3
1.90
173
1019
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
311
2108
1.54
10.71
4.2
4.1
ug/l
13.9
18.3
0.25
260
1730
(3024980) IgG subclass 4 [Mass/volume] in Serum
69
289
2.43
10.54
1.5
1.7
g/l
0.8
0.8
0.04
53
223
(3014576) Chloride [Moles/volume] in Serum or Plasma
367
2587
1.49
10.49
8.8
6.7
mmol/l
104.5
104.2
0.53
362
2527
(3007566) Smooth muscle Ab [Titer] in Serum
105
525
2.04
10.45
1.2
1.2
titre
64.3
94.2
—
7
45
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
112
574
2.00
10.41
1.8
1.5
g/l
0.2
0.2
0.87
102
543
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
40
127
3.18
10.29
1.5
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
114
593
1.97
10.17
1.8
1.5
g/l
1.1
1.2
0.77
104
561
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
82
379
2.20
10.00
1.5
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
40
130
3.11
9.91
1.5
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
332
2320
1.50
9.88
2.1
1.7
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
75
340
2.24
9.60
1.4
1.4
u/ml
94.3
119.7
0.76
12
62
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
89
435
2.08
9.44
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
89
435
2.08
9.44
1.4
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
51
196
2.64
9.35
2.8
3.2
%
58.0
56.4
0.16
38
126
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2093
19599
1.42
9.24
5.4
4.6
mmol/l
6.0
5.9
1.30
1925
17767
(3000492) Spirometry study
272
1850
1.53
9.19
1.6
1.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
144
836
1.77
9.13
1.9
1.9
u/l
42.0
38.6
1.04
118
737
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
80
382
2.13
9.03
1.4
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
319
2256
1.47
8.91
2.1
1.8
%
1.5
1.5
0.15
276
1960
(3022621) pH of Urine by Test strip
211
1364
1.60
8.91
3.5
3.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
259
1756
1.53
8.87
2.6
3.0
ng/l
214.2
199.1
0.19
234
1604
(3024354) Oxygen [Partial pressure] in Venous blood
240
1601
1.55
8.85
6.4
3.0
kpa
4.6
4.6
0.12
227
1558
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
269
1841
1.52
8.82
2.4
2.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2218
21033
1.48
8.78
21.6
13.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
21
48
4.40
8.61
3.9
4.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
84
422
2.02
8.32
6.5
3.0
—
—
—
0
0
(4062490)
46
179
2.60
8.26
1.3
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
121
688
1.80
8.25
2.6
2.4
g/l
0.6
1.0
0.89
97
602
(3052851) Hemolysis interference index of Serum or Plasma
113
630
1.83
8.22
3.5
3.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
104
565
1.88
8.21
3.9
2.6
g/l
3.4
3.6
0.81
99
532
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
13
9
14.51
8.20
2.4
2.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
208
1367
1.57
8.19
4.0
3.0
e9/l
4.1
4.1
0.15
165
1059
(3009445) Proteinase 3 Ab [Units/volume] in Serum
141
840
1.72
8.19
1.3
1.5
u/ml
14.1
20.9
—
6
22
(3052592) Norovirus Ag [Presence] in Stool
17
34
5.03
8.14
1.4
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
66
306
2.19
8.06
1.3
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
497
3870
1.35
7.95
3.2
3.0
mmol/l
2.4
2.5
0.80
422
3406
(3028192) IgG subclass 2 [Mass/volume] in Serum
45
177
2.57
7.92
1.2
1.5
g/l
2.8
2.8
0.08
32
123
(3024139) IgG subclass 3 [Mass/volume] in Serum
45
177
2.57
7.92
1.2
1.5
g/l
0.3
0.4
0.44
32
123
(3027135) IgG subclass 1 [Mass/volume] in Serum
45
177
2.57
7.92
1.2
1.5
g/l
7.0
6.8
0.07
31
124
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
322
2334
1.44
7.88
2.2
1.7
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
97
523
1.89
7.85
2.0
2.1
mg/l
11.9
11.9
0.01
88
476
(3044927) Protein electrophoresis panel - Urine
51
214
2.41
7.85
1.2
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
58
258
2.28
7.83
3.1
2.2
mg/l
28.3
25.9
0.14
23
69
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
554
4402
1.33
7.72
1.8
1.7
pmol/l
31933190.6
27243230.1
0.07
476
3645
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
134
801
1.71
7.70
1.1
1.1
—
1.7
—
0
9
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
33
112
2.97
7.66
1.2
1.2
u/l
83.8
82.4
0.04
24
99
(3048929) Epstein Barr virus Ab [Presence] in Serum
104
579
1.83
7.62
1.4
1.2
—
—
—
0
0
(4035726)
257
1800
1.48
7.52
1.4
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
55
244
2.28
7.48
1.5
1.3
nmol/l
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
85
446
1.94
7.48
2.7
2.3
g/l
123.6
129.8
1.23
56
324
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
35
125
2.83
7.43
1.9
2.5
e6/l
611.0
512.4
0.31
30
108
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
72
357
2.05
7.42
1.4
1.3
u/ml
273.7
260.9
0.14
47
211
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
32
109
2.96
7.39
1.2
1.2
u/l
19.2
17.0
0.22
25
95
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
34
120
2.86
7.37
2.0
2.5
e9/l
0.3
0.2
0.78
29
107
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
20
50
4.02
7.34
2.8
2.7
au/ml
120.8
53.7
—
5
9
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
111
638
1.77
7.34
2.3
2.3
g/l
37.0
37.7
0.45
89
554
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
92
499
1.88
7.33
1.6
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
68
332
2.08
7.31
1.5
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
57
260
2.22
7.27
1.4
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
46
191
2.43
7.26
2.5
2.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
47
198
2.40
7.20
3.6
3.9
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
95
524
1.85
7.19
1.1
1.1
u/ml
2.9
6.4
—
7
59
(3051651) Icteric interference index of Serum or Plasma
34
122
2.81
7.17
3.9
3.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
188
1247
1.55
7.13
1.5
1.3
u/ml
313.6
207.4
0.63
175
1146
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
36
134
2.71
7.09
1.9
2.2
e6/l
952.8
652.5
0.97
17
56
(3017181) Myelocytes/100 leukocytes in Blood
240
1678
1.48
7.09
4.6
4.1
%
0.9
0.9
0.03
98
478
(3004616) Nuclear Ab [Presence] in Serum
54
244
2.24
7.06
1.4
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
94
522
1.83
6.97
3.6
3.1
mmol/l
24.3
24.9
0.62
86
450
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
37
141
2.65
6.97
1.4
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
183
1213
1.55
6.97
3.0
3.4
pmol/l
4.4
4.5
0.52
160
1067
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
60
285
2.13
6.94
1.5
1.3
nmol/l
0.1
0.4
—
6
18
(3042631) Mycobacterium sp identified in Specimen
58
272
2.16
6.93
2.6
2.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
98
553
1.80
6.91
1.3
1.2
u/ml
36.0
34.6
—
6
31
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
166
1079
1.58
6.89
8.7
9.8
mmol/l
24.4
24.4
0.11
154
1012
(3049717) Cytology report of Urine Cyto stain
129
790
1.67
6.81
2.5
2.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1142
10067
1.25
6.77
4.7
3.7
estimate
0.0
0.0
1.08
190
1802
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
28
5.02
6.70
5.7
5.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
112
664
1.72
6.67
2.5
2.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
237
1674
1.46
6.65
2.2
1.9
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
31
111
2.82
6.58
2.2
1.7
u/field
0.9
2.1
1.51
14
84
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
87
484
1.83
6.44
1.8
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
196
1345
1.50
6.36
2.2
2.2
nmol/l
12.7
12.7
0.05
169
1183
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
43
185
2.35
6.32
2.3
2.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
45
198
2.30
6.29
1.8
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
55
263
2.12
6.29
1.5
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
44
192
2.31
6.27
1.2
1.2
u/l
48.1
55.5
0.68
28
135
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
42
181
2.34
6.16
1.3
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
21
62
3.41
6.14
2.0
1.6
—
—
—
0
0
(3024731) MCV [Entitic volume]
2326
22487
1.50
6.10
34.9
20.9
fl
91.2
91.1
0.87
2304
22137
(3035941) MCH [Entitic mass]
2326
22488
1.50
6.09
34.8
20.8
pg
30.3
30.3
0.84
2303
22135
(3026361) Erythrocytes [#/volume] in Blood
2326
22490
1.49
6.07
35.0
20.9
e12/l
4.4
4.5
11.33
2283
21809
(3007461) Platelets [#/volume] in Blood
2325
22480
1.49
6.05
35.0
20.9
e9/l
255.4
250.7
2.28
2286
21872
(3002179) Metamyelocytes/100 leukocytes in Blood
216
1528
1.45
6.02
4.3
3.9
%
1.1
0.6
0.52
62
344
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
12
23
5.24
6.01
6.6
8.6
mmol/l
4.2
6.0
1.85
12
23
(3010813) Leukocytes [#/volume] in Blood
2326
22496
1.49
5.99
35.1
21.0
e9/l
6.9
6.7
2.32
2281
21814
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
57
282
2.05
5.98
3.3
2.4
u/ml
327.8
62.7
0.38
57
270
(3000963) Hemoglobin [Mass/volume] in Blood
2326
22497
1.49
5.98
35.3
21.1
g/l
131.7
134.8
17.59
2301
22145
(3003396) Base excess in Arterial blood by calculation
310
2340
1.37
5.97
7.4
7.4
mmol/l
0.9
1.2
0.60
241
1823
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
60
303
2.00
5.95
1.2
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
41
178
2.33
5.93
2.1
2.3
e9/l
1.3
1.1
0.49
20
109
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
30
112
2.70
5.92
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
30
112
2.70
5.92
1.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
68
360
1.91
5.90
1.8
1.6
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
75
411
1.85
5.86
1.3
1.2
u/ml
1.7
4.7
—
6
30
(3021589) Normoblasts [#/volume] in Blood
1022
8997
1.23
5.85
14.8
9.5
e9/l
0.0
0.0
0.33
829
7355
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1972
18623
1.28
5.81
6.9
5.8
mmol/mol
40.6
39.9
2.19
1847
17162
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
151
1004
1.54
5.71
1.1
1.0
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
101
609
1.69
5.70
2.5
2.3
g/l
0.0
0.0
1.19
89
563
(3045414) Leukocytes [Presence] in Urine
144
948
1.55
5.69
2.0
1.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
63
332
1.92
5.56
1.6
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
82
470
1.77
5.55
1.8
1.5
—
—
—
0
0
(4024509)
44
203
2.19
5.54
1.6
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
339
2624
1.34
5.54
1.4
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
193
1359
1.46
5.53
2.6
2.4
au/ml
22.3
24.3
—
7
68
(3024891) Influenza virus A+B Ag [Presence] in Specimen
91
540
1.71
5.46
1.3
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
19
57
3.35
5.44
1.9
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
19
57
3.35
5.44
2.2
2.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
16
43
3.74
5.36
1.6
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
74
416
1.80
5.36
1.6
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
88
521
1.71
5.33
1.3
1.2
u/ml
6.0
10.1
0.40
18
87
(3014148) Varicella zoster virus Ab [Titer] in Serum
45
213
2.13
5.33
1.2
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
39
174
2.26
5.33
2.1
2.3
u/field
2.7
1.9
0.27
14
73
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
95
577
1.67
5.25
2.3
2.3
g/l
0.0
0.0
0.00
83
533
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
413
3312
1.30
5.22
1.6
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
28
108
2.61
5.22
1.4
1.3
nmol/l
156.1
140.9
0.47
28
108
(3006922) Hepatitis E virus Ab [Presence] in Serum
29
114
2.56
5.21
1.0
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
220
1605
1.41
5.20
4.7
4.1
%
0.1
0.1
0.11
92
442
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2004
19032
1.27
5.19
4.5
3.9
mmol/l
1.4
1.3
3.05
1843
17317
(3034860) Kappa light chains.free [Mass/volume] in Serum
104
649
1.63
5.18
4.7
3.4
mg/l
67.3
62.4
0.08
85
531
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
115
736
1.59
5.16
4.3
3.4
u/ml
266.4
5563.2
0.80
95
630
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
94
572
1.67
5.16
2.3
2.4
g/l
0.0
0.0
0.00
83
532
(3027801) Oxygen [Partial pressure] in Arterial blood
305
2349
1.34
5.15
7.6
7.4
kpa
12.0
12.2
0.20
289
2239
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
305
2349
1.34
5.15
7.6
7.4
kpa
5.0
5.1
0.54
287
2239
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
52
264
1.99
5.13
1.1
1.1
u/ml
2.4
2.5
0.01
14
106
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
74
422
1.78
5.12
2.7
3.4
u/ml
209.0
966.3
0.66
67
395
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
49
244
2.03
5.10
1.1
1.1
—
—
—
0
0
(4010399)
201
1449
1.42
5.09
1.5
1.4
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
8
6
13.37
5.08
3.8
2.3
mg/l
3.6
4.4
—
8
6
(21494815) CD4 cells/100 lymphocytes in Specimen
36
159
2.28
5.05
2.1
2.2
%
45.2
45.4
—
6
22
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
91
553
1.67
5.03
5.2
4.2
mg/l
1.9
1.5
1.83
85
505
(1616796) Gas panel - Central venous blood
77
448
1.74
4.99
4.1
3.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
189
1353
1.43
4.98
3.8
4.8
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
274
2090
1.35
4.93
7.6
7.8
%
94.8
95.5
0.69
264
2015
(3021601) Nitrite [Presence] in Urine by Test strip
1109
9959
1.20
4.92
6.6
5.0
estimate
0.0
0.0
0.50
197
1863
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
99
620
1.62
4.88
2.5
2.4
%
92.3
90.4
0.32
94
581
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
85
512
1.68
4.87
1.3
1.2
u/ml
4.5
2.4
0.58
13
49
(3009542) Hematocrit [Volume Fraction] of Blood
1938
18375
1.24
4.85
25.4
15.3
%
38.2
39.6
6.22
1373
12996
(3009508) Creatinine [Moles/volume] in Urine
741
6407
1.22
4.84
3.5
3.1
mmol/l
7.3
7.4
0.40
609
5374
(3028626) Oxygen [Partial pressure] in Capillary blood
83
498
1.69
4.83
5.0
3.0
kpa
8.1
8.2
0.22
78
458
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
55
292
1.90
4.79
1.5
1.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
102
649
1.60
4.72
4.8
3.4
mg/l
42.0
72.3
0.78
83
533
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2115
20274
1.28
4.71
5.5
4.9
mmol/l
2.7
2.7
1.69
1965
18582
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
32
139
2.32
4.68
1.2
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
588
6876
0.81
4.67
3.1
2.9
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
18
58
3.12
4.63
1.8
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1101
9921
1.20
4.61
4.6
3.7
estimate
0.0
0.0
0.00
188
1834
(3023420) DNA double strand Ab [Units/volume] in Serum
42
206
2.06
4.58
1.4
1.4
—
30.4
—
0
9
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
99
631
1.59
4.56
4.9
3.4
ratio
3.0
1.6
—
8
55
(3040151) Glucose [Moles/volume] in Capillary blood
45
228
1.99
4.51
7.1
6.4
mmol/l
7.8
7.5
0.19
40
193
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
57
313
1.84
4.50
1.2
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
128
868
1.50
4.48
1.3
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
51
271
1.90
4.46
1.2
1.1
g/l
1.6
1.5
0.28
45
249
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
123
829
1.51
4.43
6.3
5.3
%
1.6
1.6
0.16
117
772
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
25
100
2.52
4.38
1.7
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
25
100
2.52
4.38
1.7
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
25
100
2.52
4.38
1.7
1.5
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
13
35
3.73
4.36
1.2
1.1
%
99.8
94.9
0.30
13
35
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
35
3.73
4.36
1.2
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
17
55
3.11
4.36
1.1
1.2
pmol/l
267.9
290.4
—
9
39
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
154
1091
1.44
4.32
10.1
10.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
729
6357
1.21
4.28
4.2
3.9
mg/mmol
14.0
9.0
1.34
460
3976
(3016018) Differential panel - Cerebral spinal fluid
41
206
2.01
4.22
1.5
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
48
256
1.89
4.17
1.4
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
27
115
2.36
4.16
1.9
1.7
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
24
97
2.49
4.13
1.5
2.7
u/ml
1347.4
1287.0
0.05
24
97
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
117
793
1.50
4.13
2.3
1.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2073
19893
1.25
4.12
5.0
4.4
mmol/l
4.6
4.7
1.66
1928
18361
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
61
353
1.75
4.09
1.8
1.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
10
23
4.36
4.09
1.7
1.9
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
10
23
4.36
4.09
1.8
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
98
641
1.55
4.08
1.1
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
21
80
2.64
4.06
1.3
7.9
mg/l
46.8
67.2
1.32
13
61
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
29
129
2.26
4.06
1.9
2.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
49
267
1.85
4.00
1.1
1.1
u/ml
1.2
3.1
0.87
13
65
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
29
130
2.25
3.99
1.1
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
67
402
1.69
3.96
1.2
1.2
u/ml
52.1
43.4
0.20
14
39
(3051611) Lipemic interference index of Serum or Plasma
41
212
1.95
3.92
3.9
3.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
24
100
2.41
3.89
1.7
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
200
1510
1.35
3.89
4.8
4.2
%
0.0
0.5
0.99
76
373
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
82
521
1.59
3.88
1.6
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
69
420
1.66
3.87
1.6
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2056
19744
1.23
3.87
5.0
4.4
mmol/l
1.4
1.5
3.14
1901
18091
(3047181) Lactate [Moles/volume] in Blood
94
618
1.54
3.84
5.7
6.5
mmol/l
1.2
1.3
0.83
85
533
(3007930) Methemoglobin/Hemoglobin.total in Blood
119
823
1.47
3.82
6.5
5.4
%
0.9
0.9
0.33
112
768
(3014271) Vancomycin [Susceptibility]
24
101
2.39
3.81
3.1
2.9
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
27
122
2.23
3.67
1.7
1.6
u/l
4.8
7.1
0.39
14
58
(3012516) Albumin [Mass/volume] in Urine
688
6043
1.19
3.65
3.8
3.2
mg/l
759.2
302.0
1.17
452
3797
(3009214) Lutropin [Units/volume] in Serum or Plasma
76
482
1.59
3.64
1.5
1.5
u/l
8.8
9.5
0.21
68
396
(3037756) Immunofixation for Serum or Plasma
70
436
1.62
3.61
2.0
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
62
375
1.67
3.58
4.1
2.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
47
263
1.80
3.56
1.7
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
54
315
1.73
3.56
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
149
1092
1.39
3.51
4.8
3.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
13
41
3.18
3.49
1.2
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
99
673
1.49
3.49
5.3
3.3
u/ml
0.3
0.4
1.98
51
389
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
18
69
2.62
3.47
1.3
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
40
216
1.87
3.41
2.0
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
80
523
1.55
3.39
1.3
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
550
4763
1.20
3.39
4.1
3.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
20
82
2.45
3.38
1.8
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
20
82
2.45
3.38
1.8
1.5
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
9
18
5.01
3.37
2.0
2.4
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
7
10
7.01
3.36
1.9
1.5
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
7
10
7.01
3.36
1.0
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
107
745
1.46
3.36
1.3
1.2
u/ml
0.2
0.9
—
8
59
(3028707) Methadone [Presence] in Urine by Screen method
48
276
1.75
3.35
1.8
2.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
223
1752
1.30
3.32
2.3
2.4
ug/l
6.6
6.9
0.09
187
1541
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
20
83
2.42
3.30
1.8
1.5
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
14
48
2.93
3.30
1.5
2.8
e6/l
273.8
217.8
—
8
23
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
18
71
2.55
3.29
3.0
2.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
243
1933
1.28
3.29
8.6
8.2
g/l
119.2
121.7
1.13
237
1860
(3000093) Morphology [Interpretation] in Blood Narrative
34
176
1.94
3.29
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
204
1586
1.31
3.28
3.2
2.6
ml/min/173m2
65.4
66.0
0.07
83
634
(3003888) Timothy IgE Ab [Units/volume] in Serum
50
293
1.72
3.27
1.1
1.1
u/ml
2.9
6.6
1.60
33
155
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
66
417
1.60
3.25
1.6
1.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
84
562
1.51
3.22
2.8
2.5
%
209.5
186.4
1.85
79
537
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
37
199
1.87
3.21
2.1
1.5
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
15
5.35
3.19
1.7
1.2
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
44
251
1.77
3.17
2.0
1.4
mu/l
65.6
44.3
0.79
38
223
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41
229
1.80
3.16
1.7
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
80
532
1.52
3.16
5.8
4.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
30
151
2.00
3.15
1.2
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
36
195
1.86
3.07
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
85
577
1.49
3.06
2.6
1.8
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
28
139
2.03
3.05
1.9
2.3
%
16.5
13.4
0.35
15
61
(3014891) Appearance of Pleural fluid
10
29
3.46
3.04
1.8
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
17
68
2.51
3.04
1.6
1.3
—
—
—
0
0
(3019977) pH of Arterial blood
23
106
2.18
3.03
1.7
3.2
ph
7.4
7.4
—
8
33
(3027456) Digoxin [Moles/volume] in Serum or Plasma
69
449
1.55
3.02
2.9
3.2
nmol/l
0.8
0.8
0.11
53
350
(3045142) Bone marrow Pathology biopsy report
42
240
1.76
3.02
1.6
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
44
255
1.74
3.02
2.0
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
89
612
1.47
3.01
1.9
1.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
30
154
1.96
2.99
1.8
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
72
475
1.53
2.97
1.6
1.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
15
57
2.64
2.96
1.3
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
24
114
2.12
2.94
1.2
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
24
114
2.12
2.94
1.2
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
22
101
2.19
2.93
1.3
1.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
73
486
1.52
2.90
4.7
3.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
133
991
1.36
2.88
2.4
1.9
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
16
64
2.51
2.87
3.1
2.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
48
290
1.67
2.85
1.6
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
31
164
1.90
2.85
1.4
1.1
u/ml
11.2
56.8
—
5
13
(3012501) Base excess in Blood by calculation
70
465
1.52
2.81
6.9
4.5
mmol/l
2.1
2.7
1.64
51
321
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
141
1065
1.34
2.80
4.2
3.3
u/ml
76.6
67.9
0.14
133
1025
(3008401) Mugwort IgE Ab [Units/volume] in Serum
47
284
1.67
2.80
1.1
1.1
u/ml
0.4
1.2
1.02
28
126
(37021550) Renin [Units/volume] in Plasma --upright
14
53
2.65
2.79
1.2
1.3
mu/l
92.3
61.2
—
7
42
(3036489) Thrombin time
104
749
1.41
2.77
2.5
2.1
s
21.8
21.7
0.16
96
662
(3039000) Anion gap in Blood
67
443
1.53
2.76
6.2
7.5
mmol/l
11.7
11.3
0.32
62
394
(3018572) Chloride [Moles/volume] in Blood
67
444
1.52
2.73
6.2
7.5
mmol/l
106.0
105.1
0.86
62
395
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
36
203
1.78
2.73
1.2
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
65
428
1.53
2.73
3.8
2.5
%
15.2
16.2
1.46
33
214
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
14
54
2.60
2.70
1.1
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
8
19
4.22
2.67
1.3
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
188
1490
1.28
2.66
1.6
1.6
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
29
154
1.89
2.66
1.8
1.5
umol/l
13.1
12.8
0.09
29
145
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
12
43
2.80
2.64
3.3
2.7
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
12
43
2.80
2.64
1.6
1.4
g/l
24.7
27.4
—
7
35
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
24
120
2.01
2.60
1.3
1.3
pmol/l
58.5
52.2
—
10
39
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
682
6133
1.15
2.58
5.2
4.9
ug/l
2.6
3.6
0.66
637
5480
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
52
330
1.59
2.58
1.1
1.1
u/ml
1.2
1.7
0.30
31
138
(3000475) Leukocytes [#/volume] in Synovial fluid
73
500
1.47
2.56
1.5
1.7
e6/l
8333.2
14790.7
1.35
54
365
(4212803)
8
20
4.01
2.56
1.1
1.1
—
—
—
0
0
(4198724)
16
68
2.36
2.55
1.7
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
57
371
1.55
2.54
2.0
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
81
568
1.44
2.53
1.6
1.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
14
56
2.51
2.53
1.1
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
14
56
2.51
2.53
1.4
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
21
101
2.09
2.53
1.3
1.4
—
—
—
0
0
(44806118)
39
231
1.70
2.52
1.8
1.5
—
—
—
0
0
(44790049)
39
231
1.70
2.52
1.8
1.5
—
—
—
0
0
(44790048)
39
231
1.70
2.52
1.8
1.5
—
—
—
0
0
(44790047)
39
231
1.70
2.52
1.8
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
56
365
1.55
2.49
1.5
1.6
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
7
16
4.38
2.47
1.0
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
57
374
1.54
2.46
2.8
1.4
mmol/l
54.4
61.2
0.65
47
302
(3011335) Digoxin [Mass/volume] in Serum or Plasma
8
21
3.82
2.46
1.4
2.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
31
173
1.80
2.46
1.6
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
31
173
1.80
2.46
1.6
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
31
173
1.80
2.46
1.6
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
26
137
1.91
2.45
1.5
1.4
promille
1.0
1.3
0.30
18
104
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
37
218
1.71
2.45
1.8
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
35
203
1.73
2.45
1.7
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
10
34
2.95
2.41
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
45
281
1.61
2.40
1.4
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
36
212
1.71
2.39
2.9
2.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
31
175
1.78
2.38
1.3
1.3
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
5
8
6.26
2.37
1.0
1.0
—
—
—
0
0
(4281824)
38
229
1.67
2.33
1.2
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
42
260
1.63
2.33
4.2
2.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
12
47
2.56
2.27
1.6
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
45
287
1.58
2.22
1.2
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
100
746
1.35
2.22
1.5
1.4
iu/l
20.5
30.0
3.11
86
637
(3048879) Bone marrow aspiration report
13
54
2.41
2.19
1.5
1.7
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
24
3.34
2.18
1.1
1.0
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
24
129
1.87
2.17
1.9
1.3
u/l
13.1
13.7
0.18
24
122
(4015189)
13
55
2.37
2.12
1.7
2.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
28
160
1.76
2.09
2.4
2.6
%
11.2
11.3
0.08
28
160
(3023430) Cat dander IgE Ab [Units/volume] in Serum
33
198
1.68
2.09
1.1
1.1
u/ml
4.4
4.3
0.01
16
83
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
30
176
1.71
2.06
1.2
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
7
20
3.51
2.05
1.6
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
74
533
1.40
2.05
1.2
1.3
miu/ml
154.4
236.4
1.19
30
237
(3051593) INR in Capillary blood by Coagulation assay
19
96
1.99
2.05
1.6
14.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
64
451
1.43
2.01
1.8
1.5
e6/l
13.3
32.3
0.69
50
349
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
64
451
1.43
2.01
1.9
1.5
e6/l
1011.5
1555.0
0.28
52
366
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
32
194
1.66
1.96
1.2
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
18
91
1.99
1.95
1.9
2.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
75
547
1.38
1.95
2.5
2.2
u/l
4558.5
3790.9
0.12
25
216
(3028300) Cannabinoids [Presence] in Urine
83
616
1.36
1.94
1.6
1.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
32
195
1.65
1.93
1.3
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
44
290
1.53
1.93
1.3
1.2
u/ml
4.6
5.1
0.09
23
122
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
10
39
2.57
1.92
1.1
1.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
16
78
2.06
1.91
3.5
2.6
umol/l
176.1
139.5
—
10
40
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
20
106
1.89
1.90
2.6
3.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
39
251
1.56
1.90
3.5
2.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
78
576
1.37
1.89
1.5
1.6
mu/l
387.5
301.2
0.57
71
525
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
7
22
3.19
1.88
1.0
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
60
425
1.42
1.85
3.0
1.9
nmol/l
0.8
0.8
0.17
49
355
(40759836) Histone Ab [Presence] in Serum by Immunoblot
25
144
1.74
1.85
1.5
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
25
144
1.74
1.85
1.5
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
25
144
1.74
1.85
1.5
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
82
613
1.35
1.84
1.6
1.8
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
37
237
1.57
1.84
1.3
1.4
pmol/l
406.4
309.0
0.58
28
179
(3005570) Glucose [Moles/volume] in Urine
34
214
1.60
1.82
2.2
2.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
53
368
1.45
1.82
4.4
3.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
7
23
3.05
1.80
1.1
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
8
29
2.76
1.79
1.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
29
2.76
1.79
1.9
2.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
25
146
1.72
1.77
1.7
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
25
146
1.72
1.77
1.5
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
25
146
1.72
1.77
1.5
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
25
146
1.72
1.77
1.5
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
124
1.78
1.76
1.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
81
610
1.34
1.75
1.6
1.8
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
17
88
1.94
1.74
1.1
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
16
81
1.98
1.74
1.0
1.1
miu/ml
1510.2
1656.4
0.17
16
81
(3032868) Hemoglobin electrophoresis panel in Blood
7
24
2.92
1.72
1.7
1.5
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
(3025315) Body weight
5
13
3.85
1.71
6.2
3.7
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
38
250
1.53
1.71
1.6
1.6
%
60.3
60.5
0.01
32
159
(3030905) Polymorphonuclear cells [#/volume] in Blood
55
391
1.42
1.69
5.1
3.5
e9/l
4.2
4.1
0.06
55
391
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
24
141
1.71
1.68
1.0
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
35
227
1.55
1.68
1.3
1.4
mosm/kgh2o
286.2
279.4
0.84
25
172
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
40
268
1.50
1.66
1.2
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
30
188
1.60
1.66
2.3
2.0
umol/l
4.3
7.3
1.15
23
129
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
8
31
2.59
1.66
3.4
3.1
umol/l
41.6
43.4
—
8
24
(3037692) Legionella sp identified in Specimen by Organism specific culture
14
69
2.03
1.64
1.4
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
12
56
2.15
1.61
1.2
1.2
—
—
—
0
0
(4268621)
31
198
1.57
1.59
2.3
2.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
16
84
1.91
1.59
3.6
3.6
—
—
—
0
0
(3010421) pH of Blood
74
562
1.33
1.54
6.7
4.2
ph
7.4
7.4
0.73
68
460
(3014051) Protein [Presence] in Urine by Test strip
69
520
1.34
1.52
2.4
2.1
—
—
—
0
0
(4146454)
35
233
1.51
1.52
2.4
2.6
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
7
27
2.60
1.51
3.3
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
482
4383
1.12
1.51
6.3
4.5
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
6
21
2.86
1.50
1.0
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
33
218
1.52
1.49
1.1
1.0
u/ml
21.0
3.4
0.57
15
83
(3045683) HLA typing for celiac disease panel - Blood or Tissue
18
101
1.79
1.48
1.0
1.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
29
187
1.56
1.45
1.0
1.0
u/ml
0.1
0.5
—
10
47
(3027944) Amphetamines [Presence] in Urine
78
603
1.30
1.45
1.7
1.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
16
88
1.82
1.41
1.3
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
55
407
1.36
1.38
6.2
3.8
%
57.8
57.6
0.04
55
407
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
60
2.00
1.38
1.2
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
24
150
1.61
1.38
1.7
2.0
mmol/l
8.3
6.8
0.84
16
95
(3008152) Bicarbonate [Moles/volume] in Arterial blood
152
1278
1.20
1.37
6.6
6.9
mmol/l
23.9
24.5
0.97
146
1186
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
36
247
1.46
1.37
2.3
1.8
titre
976.0
1474.3
—
5
7
(3002619) Bacteria identified in Specimen by Culture
9
41
2.20
1.37
1.9
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
22
135
1.64
1.35
2.1
1.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
9
42
2.15
1.33
1.8
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
18
105
1.72
1.33
1.4
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
54
2.04
1.32
1.2
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
15
83
1.81
1.31
1.1
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
12
62
1.94
1.27
1.3
1.3
—
—
—
0
0
(4133840)
9
44
2.05
1.26
1.1
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
23
146
1.58
1.26
1.2
1.2
u/ml
0.1
0.6
0.98
12
71
(44806071)
6
25
2.40
1.24
1.2
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
71
556
1.29
1.24
1.5
1.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
28
187
1.50
1.24
3.9
4.9
u/ml
27.6
45.0
—
8
50
(40768806) Pleura Pathology biopsy report
31
212
1.47
1.23
1.9
1.5
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
19
2.63
1.21
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
20
124
1.62
1.20
1.2
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
13
71
1.84
1.19
1.2
1.5
—
1903858.3
—
0
6
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
38
2.11
1.18
1.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
64
1.88
1.18
1.4
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
11
57
1.93
1.17
1.5
2.1
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
33
0.00
1.16
0.0
1.1
—
2.4
—
0
23
(3000285) Sodium [Moles/volume] in Blood
0
34
0.00
1.16
0.0
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
20
2.50
1.15
1.6
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
20
2.50
1.15
8.8
4.9
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
20
2.50
1.15
1.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
65
1.85
1.13
1.4
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
17
103
1.65
1.12
1.1
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
7
30
2.34
1.12
1.7
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
227
2554
0.88
1.11
9.9
6.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
39
285
1.37
1.10
1.8
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
30
209
1.44
1.10
1.5
1.7
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
12
66
1.82
1.09
1.5
2.3
e6/l
646.7
27033.6
—
6
43
(40757373) Influenza virus identified in Isolate
8
41
1.95
1.08
1.3
1.7
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
20
128
1.57
1.08
1.0
1.1
nmol/l
1.0
3.1
—
6
28
(3011288) Drugs identified in Urine by Screen method
55
426
1.30
1.07
2.1
2.4
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
13
74
1.76
1.06
1.5
2.3
e6/l
626.3
706.9
—
7
60
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
17
105
1.62
1.06
3.1
2.5
%
94.6
97.2
0.10
17
100
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
67
1.79
1.04
1.7
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
12
67
1.79
1.04
2.6
1.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
24
162
1.49
1.04
1.6
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
22
2.28
1.03
4.0
3.1
u/field
0.2
0.6
—
5
22
(21494755) Public health laboratory ask at order entry panel
138
1599
0.86
1.03
1.3
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
114
1.58
1.02
1.2
1.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
151
1309
1.16
1.02
9.9
9.1
%
0.6
0.7
0.48
151
1302
(3028308) Erythrocytes [#/volume] in Pleural fluid
30
213
1.41
1.01
1.6
1.4
e6/l
9812.4
91720.1
1.70
21
127
(3041096) Erythrocytes [Presence] in Urine by Automated
567
5309
1.09
1.01
4.7
3.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
151
1311
1.16
1.00
10.0
9.2
%
93.0
93.8
0.56
151
1303
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
20
131
1.53
0.99
1.5
1.2
u/l
12.7
12.7
0.00
20
120
(3019174) dRVVT (LA screen)
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
236
2122
1.12
0.95
4.1
3.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
62
1.78
0.94
1.5
2.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
62
1.78
0.94
1.5
2.9
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
7
37
1.89
0.94
1.0
1.2
—
—
—
0
0
(4094501)
68
552
1.24
0.94
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
70
1.72
0.92
1.1
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
33
244
1.36
0.91
1.6
1.4
e6/l
1471.3
1815.1
0.31
28
173
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
48
607
0.79
0.89
1.4
1.5
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
29
2.07
0.89
1.2
1.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
150
1317
1.15
0.88
9.9
9.0
%
1.4
1.3
0.29
150
1309
(3024932) HLA-DR beta [Type]
10
56
1.79
0.87
1.0
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
30
2.00
0.87
5.8
3.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
30
2.00
0.87
1.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
30
2.00
0.87
11.7
6.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
62
504
1.24
0.86
1.8
1.9
iu/l
2.6
4.9
2.76
17
171
(3027923) C peptide [Moles/volume] in Serum or Plasma
16
104
1.54
0.84
1.6
1.4
nmol/l
1.1
1.2
0.31
11
82
(3024869) Neuronal Ab [Presence] in Serum
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
31
1.94
0.84
3.0
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
23
162
1.42
0.84
1.1
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
27
196
1.38
0.84
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
39
301
1.30
0.83
1.3
1.2
u/ml
1.9
2.7
0.47
14
96
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
121
1.49
0.82
1.4
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
32
1.88
0.81
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
64
526
1.22
0.81
1.1
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
16
105
1.53
0.81
1.8
2.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
16
105
1.53
0.81
1.5
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
12
73
1.65
0.81
1.6
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
10
58
1.73
0.79
1.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
48
1.67
0.78
1.3
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
15
98
1.53
0.78
1.6
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
22
157
1.40
0.76
1.3
1.4
mmol/l
13.1
12.3
—
9
46
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
27
200
1.35
0.76
1.9
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
18
124
1.45
0.75
1.2
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
18
124
1.45
0.75
2.6
2.8
%
46.3
38.3
—
9
41
(3051387) C reactive protein [Mass/volume] in Capillary blood
56
459
1.23
0.75
4.6
3.7
mg/l
31.0
26.7
0.37
34
293
(21494814) CD8 cells/100 lymphocytes in Specimen
12
75
1.60
0.75
2.2
1.8
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
25
2.00
0.72
1.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
14
92
1.52
0.72
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
87
747
1.17
0.72
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
42
335
1.26
0.72
1.8
1.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
13
84
1.55
0.72
1.1
1.1
iu/ml
124.5
219.6
1.26
13
84
(40768795) Lymph node Pathology biopsy report
25
186
1.35
0.70
1.2
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
58
1.55
0.69
1.1
1.2
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
9
58
1.55
0.69
1.1
1.3
mmol/l
3.1
3.2
—
9
51
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
13
85
1.53
0.69
1.0
1.0
—
9.3
—
0
12
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
42
1.67
0.68
2.3
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
572
5451
1.06
0.65
1.7
1.6
mmol/l
1.4
1.4
0.88
496
4568
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
16
224
0.71
0.64
1.3
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
377
3547
1.07
0.63
3.2
3.1
ug/l
0.9
0.8
0.52
264
2353
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
31
243
1.28
0.62
1.2
1.3
mmol/l
7.1
7.5
0.36
25
174
(3036071) Salmonella sp Ab [Titer] in Serum
11
71
1.55
0.62
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
148
1336
1.11
0.62
1.2
1.2
iu/ml
148.5
143.0
0.04
36
510
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
30
1.67
0.61
1.8
1.6
ng/l
139.8
114.2
—
5
30
(40761535) Cells panel - Urine sediment
186
1701
1.10
0.61
3.8
3.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
13
88
1.48
0.60
2.3
1.9
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
31
245
1.27
0.59
1.1
1.4
u/l
27.4
26.3
0.06
24
199
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
54
638
0.84
0.58
1.5
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
37
300
1.24
0.58
1.4
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
576
5516
1.06
0.56
1.4
1.4
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
37
1.62
0.55
1.8
2.9
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
35
284
1.24
0.55
1.3
1.1
%
118.4
115.1
0.21
29
257
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
29
362
0.80
0.55
1.6
1.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
6
38
1.58
0.54
5.0
5.8
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
60
1.50
0.54
2.0
1.9
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
9
61
1.48
0.53
1.1
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
39
322
1.21
0.53
1.3
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
15
108
1.39
0.53
1.2
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
227
2113
1.08
0.52
1.7
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
19
143
1.33
0.52
1.9
2.2
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
9
64
1.41
0.51
3.7
7.1
mmol/l
25.6
25.5
—
9
59
(3000034) Microalbumin [Mass/volume] in Urine
24
188
1.28
0.51
2.2
3.0
mg/l
95.7
34.7
0.32
16
140
(3020874) Milk IgE Ab [Units/volume] in Serum
13
92
1.42
0.50
1.0
1.1
u/ml
0.2
1.4
—
5
35
(3047189) Immunofixation for 24 hour Urine
13
92
1.42
0.50
2.2
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
45
1.56
0.49
1.1
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
46
1.52
0.48
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
42
355
1.19
0.47
1.3
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
36
300
1.20
0.46
1.4
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1655
16786
0.96
0.46
30.5
17.3
%
14.0
13.7
7.58
1635
16397
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
14
103
1.36
0.45
1.1
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
14
103
1.36
0.45
1.6
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
84
937
0.89
0.45
1.8
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
22
275
0.80
0.44
1.5
1.5
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
12
86
1.40
0.44
1.3
1.1
ng/l
98.8
137.9
—
5
22
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
16
121
1.32
0.44
1.3
1.1
ratio
1.0
1.0
—
5
43
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
182
1698
1.08
0.42
1.5
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
32
1.56
0.42
1.4
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
13
96
1.36
0.41
1.4
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
33
1.52
0.41
1.4
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
59
1.36
0.41
1.3
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
510
4921
1.05
0.39
4.6
4.3
%
21.5
21.5
0.01
238
2391
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
13
97
1.34
0.39
1.5
2.3
umol/l
57.6
51.5
—
8
73
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
5
35
1.43
0.39
1.8
2.9
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
71
1.41
0.39
1.2
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
71
1.41
0.39
1.2
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(4306422)
34
288
1.18
0.39
1.3
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
80
1.38
0.38
1.4
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
518
5358
0.96
0.37
5.0
4.0
estimate
0.0
0.0
1.28
194
1798
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
37
1.35
0.37
1.6
2.4
umol/l
20.4
16.6
—
5
37
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
17
134
1.27
0.37
1.6
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
22
267
0.82
0.36
1.5
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
90
1.33
0.35
1.4
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
34
291
1.17
0.35
1.2
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
42
1.43
0.35
3.7
2.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
22
266
0.83
0.35
1.4
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
80
729
1.10
0.34
1.7
1.7
mg/l
5.1
3.8
0.28
63
513
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
45
1.33
0.33
1.0
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1721
17026
1.03
0.33
30.3
18.4
g/l
331.0
332.2
5.88
1707
16898
(3024263) Appearance of Synovial fluid
14
109
1.29
0.33
1.9
1.8
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
46
1.31
0.33
1.2
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
162
1717
0.94
0.31
6.2
4.0
—
—
—
0
0
(3044889) 12 lead EKG panel
1448
14298
1.03
0.30
4.1
3.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
300
3119
0.96
0.29
1.5
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
29
334
0.87
0.28
1.2
1.1
iu/ml
33.4
124.2
—
6
76
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
67
1.19
0.26
1.1
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
67
1.19
0.26
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
37
413
0.89
0.24
1.4
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
28
246
1.14
0.23
1.0
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
13
106
1.23
0.23
2.2
2.6
ml
2216.9
1947.2
0.27
13
92
(3044941) Cell count panel - Synovial fluid
37
333
1.11
0.22
1.6
1.5
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
14
116
1.21
0.22
1.1
1.1
u/l
0.9
1.2
—
9
64
(40758358) Immune stain study
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
2.6
—
0
10
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
25
220
1.14
0.21
2.0
1.8
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
15
126
1.19
0.21
5.6
6.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
15
177
0.85
0.21
1.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
30
335
0.89
0.21
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
30
335
0.89
0.21
1.4
1.4
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
0.1
—
0
7
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
6
48
1.25
0.20
1.2
1.3
%
22.5
22.9
—
6
35
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
30
334
0.90
0.20
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
30
334
0.90
0.20
1.4
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
14
118
1.19
0.19
1.3
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
772
7605
1.02
0.19
5.0
3.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
449
4394
1.03
0.19
4.6
4.1
kg/l
1.0
1.0
0.06
83
626
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
13
109
1.19
0.18
11.8
11.5
mmol/l
0.6
0.6
0.18
13
103
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
101
1062
0.95
0.18
1.4
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
24
268
0.89
0.17
1.9
1.7
—
—
—
0
0
(44806420)
7
62
1.13
0.17
2.6
2.5
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
69
0.72
0.17
1.2
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
76
0.79
0.15
1.0
1.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
77
0.78
0.15
1.0
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
79
0.76
0.15
1.7
1.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
10
119
0.84
0.15
1.3
2.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
78
1.15
0.15
4.6
2.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
28
307
0.91
0.15
1.5
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
37
400
0.92
0.15
1.3
1.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
21
188
1.12
0.14
1.6
1.3
mmol/l
7.2
6.6
0.57
21
175
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
10
118
0.85
0.14
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
156
1609
0.97
0.13
1.7
1.7
—
—
—
0
0
(4034850)
69
657
1.05
0.13
10.6
10.0
—
—
—
0
0
(4027681)
13
113
1.15
0.13
1.5
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
62
652
0.95
0.12
1.8
1.9
—
—
—
0
0
(3020891) Body temperature
80
834
0.96
0.12
5.4
4.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
175
1709
1.03
0.10
7.3
3.6
mmol/l
1.2
1.2
0.99
161
1476
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
19
174
1.09
0.09
1.3
1.5
ug/l
8.0
3.7
0.42
19
153
(3041806) Other cells [#/volume] in Blood by Manual count
5
48
1.04
0.09
2.6
1.6
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
5
63
0.79
0.08
1.0
1.8
pmol/l
14.8
14.7
—
5
49
(40765096) Chromosome analysis panel by Banding
6
71
0.84
0.07
1.0
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
8
78
1.03
0.07
1.0
2.2
ug/l
11.0
124.2
—
8
66
(3014599) Egg white IgE Ab [Units/volume] in Serum
10
90
1.11
0.05
1.1
1.0
u/ml
0.7
0.4
—
5
25
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
15
139
1.08
0.05
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
48
495
0.97
0.05
1.3
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
130
0.92
0.04
1.1
1.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
21
199
1.06
0.04
2.0
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
23
241
0.95
0.04
1.4
1.5
nmol/l
0.2
0.3
1.61
23
191
(3039443) Prostate specific Ag panel - Serum or Plasma
32
331
0.97
0.03
1.3
1.7
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
21
201
1.05
0.03
1.5
1.4
e6/l
388891.2
104156.7
0.43
12
138
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
63
639
0.99
0.01
1.5
1.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
16
167
0.96
0.01
1.9
2.1
ml
667.3
611.1
—
8
114
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
14
146
0.96
0.00
1.2
1.3
—
743.1
—
0
13
(44813793)
14
135
1.04
0.00
1.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
50
502
1.00
0.00
2.4
2.3
ug/min
159.5
101.1
0.51
28
309
(3032773) Endomysium IgG Ab [Titer] in Serum
17
173
0.98
0.00
1.1
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
62
0.97
0.00
1.3
1.4
ug/l
9.0
9.1
—
6
62
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
8
0.00
0.00
0.0
4.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
53
0.94
0.00
1.6
1.6
—
—
—
0
0
(3013862) HLA-DP [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
72
0.97
0.00
1.1
1.5
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
51
0.98
0.00
2.4
1.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint BACT_INTEST_INFECTION_NOS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| BACT_INTEST_INFECTION_NOS | 1.44 [1.3, 1.59] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.395 |
During the follow-up period (1.1.1998 — 31.12.2019), 1975 out of 8826 females with BACT_INTEST_INFECTION_NOS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| BACT_INTEST_INFECTION_NOS | 1.523 [1.36, 1.7] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.008 |
During the follow-up period (1.1.1998 — 31.12.2019), 1788 out of 7300 males with BACT_INTEST_INFECTION_NOS died.
Mortality risk
Mortality risk for people of age
years, who have BACT_INTEST_INFECTION_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.152% | 0.277% |
| 5 | 0.866% | 1.927% |
| 10 | 2.158% | 4.459% |
| 15 | 4.255% | 8.802% |
| 20 | 7.375% | 14.502% |
Relationships between endpoints
↥Index endpoint: BACT_INTEST_INFECTION_NOS – Other specified/unspecified bacterial intestinal infections
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data